Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

Group 1 - Pfizer (PFE) closed at $22.79, with a 1.3$28.52 indicating a 25.1% upside potential [1] - The average of 21 short-term price targets ranges from $23 to$35, with a standard deviation of $3.16, suggesting variability in analyst estimates [2] - Analysts have shown increasing optimism about PFE's earnings prospects, with a 3.2% increase in the Zacks Consensus Estimate for the current year and no negative revisions [12][11] Group 2 - The Zacks Rank for PFE is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - A tight clustering of price targets, indicated by a low standard deviation, suggests a high degree of agreement among analysts regarding the stock's price movement [9] - While price targets can be misleading, the direction implied by them may serve as a useful guide for further research into the stock's potential [10][7]